TriMas (NASDAQ:TRS) reported quarterly adj. earnings of $0.62 per share which missed the analyst consensus estimate of $0.65 by 4.62 percent. This is a 10.71 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $203.31 million which missed the analyst consensus estimate of $211.84 million by 4.03 percent. This is a 2.71 percent decrease over sales of $208.97 million the same period last year.
Curaleaf Settles $100,000 Class-Action Suit Following Oregon Labeling Mixup
Massachusetts-based cannabis company Curaleaf (OTC: CURLF) has settled another class-action lawsuit related to its Select brand CBD drops containing THC.
